Display Settings:

Format

Send to:

Choose Destination
    Acta Biochim Pol. 1997;44(2):231-7.

    Modification of pre-mRNA splicing by antisense oligonucleotides.

    Source

    Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 27599, USA. kole@med.unc.edu

    Abstract

    Antisene oligonucleotides have been extensively studied as agents that inhibit the expression of undesirable genes in a sequence specific manner. Results reviewed in this article show that antisene oligonucleotides can also restore the expression of genes inactivated by mutations causing genetic diseases. In this novel application, antisene oligonucleotides block aberrant splice sites created by the mutations, forcing the spliceosomes to form at correct splice sites, thus restoring the proper splicing pathway and consequently the activity of the damaged gene.

    PMID:
    9360712
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Acta Biochemica Polonica, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk